Healx Logo

menu menu
Contact
Patient Groups
  • Rare Treatment Accelerator
    • Partnerships
    Pipeline
    Technology
  • Publications
    • About
  • Careers
  • Board of directors
  • Advisory board
    • Updates
  • News
  • Healx in the media
  • Blog

    • Patient-Focused Drug Development (PFDD)

    11 January 2022   |  
    X minutes

    Patient-focused drug development (PFDD) is a systematic approach to help ensure that patients’ experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into drug development and evaluation.

    Share this story
    Healx on Facebook Healx on Twitter
    « Back to Glossary Index

    You might also like:

    In the media
    Giovanni Cincilla, Peter Wright and Triin Tammsalu explore Target Tractability with KNIME in the latest Medium blog post
    hello@douglassdigital.com
    News & Opinion
    Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences
    Robert Bogdan
    News & Opinion
    Healx and SCI Ventures join forces to uncover cures for paralysis with AI-driven drug discovery
    hello@douglassdigital.com

    © Healx. All rights reserved.

    Company registration: 09018507. VAT number GB212364641.